Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Biological Psychiatry

• Publication date

  2004-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.BIOPSYCH.2004.07.001PMID 15450785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo

  2005cited by this paper
• Regional serotonin transporter availability and depression are correlated in Wilson’s disease

  2003cited by this paper
• 5-HTTLPR Polymorphism of the Serotonin Transporter Gene Predicts Non-Remission in Major Depression Patients Treated With Citalopram in a 12-Weeks Follow Up Study

  2003cited by this paper
• Changes in Human In vivo Serotonin and Dopamine Transporter Availabilities during Chronic Antidepressant Administration

  2003cited by this paper
• The degree of depression in Hamilton rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson's disease

  2003cited by this paper
• When should a trial of fluoxetine for major depression be declared failed?

  2003cited by this paper
• Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism.

  2002cited by this paper
• Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

  2002cited by this paper
• Serotonin and Fluoxetine Levels in Plasma and Platelets After Fluoxetine Treatment in Depressive Patients

  2002cited by this paper
• Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers

  2001cited by this paper
• Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis.

  2001cited by this paper
• Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study.

  2001cited by this paper
• No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism.

  2001cited by this paper
• Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life Depression

  2000cited by this paper
• A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.

  2000cited by this paper
• Serotonin transporter gene polymorphism and antidepressant response

  2000cited by this paper
• Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression (letter). Reply to correspondence to Goodnick and Kumar

  2000cited by this paper
• Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2‐adrenergic receptors (AR)s, serotonin (5‐HT)1A, 5‐HT1B, 5‐HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

  2000cited by this paper
• A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression.

  2000cited by this paper
• Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT.

  2000cited by this paper
• A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide.

  2000cited by this paper
• Age-related decline in central serotonin transporter availability with [123I]β-CIT SPECT

  2000cited by this paper
• In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.

  2000cited by this paper
• Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients.

  2000cited by this paper
• Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene.

  2000cited by this paper
• Autoregulation of serotonin neurons: role in antidepressant drug action.

  1999cited by this paper
• Effects of Chronic Antidepressant Treatments on Serotonin Transporter Function, Density, and mRNA Level

  1999cited by this paper
• Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos.

  1999cited by this paper
• Prefrontal dysfunction and treatment response in geriatric depression.

  1999cited by this paper
• Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression.

  1999cited by this paper
• Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.

  1998cited by this paper
• Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

  1998cited by this paper
• Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography

  1998cited by this paper
• Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.

  1998cited by this paper
• Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels.

  1998cited by this paper
• Significance of nonuniform attenuation correction in quantitative brain SPECT imaging.

  1998cited by this paper
• Cingulate function in depression: a potential predictor of treatment response

  1997cited by this paper
• Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region

  1996cited by this paper
• Is There a Relationship between Baseline and Treatment-Associated Changes in [3H]-IMI Platelet Binding and Clinical Response in Major Depression?

  1996cited by this paper
• Quantitative EEG in the prediction of antidepressant response to imipramine.

  1996cited by this paper
• Imipramine binding as a predictor of fluoxetine response in depressed patients.

  1995cited by this paper
• Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects

  1994cited by this paper
• SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates

  1993cited by this paper
• Evaluation of the monoamine uptake site ligand [131I]methyl 3β-(4-Iodophenyl)-tropane-2β-carboxylate ([123I]β-CIT) in non-human primates: Pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI

  1993cited by this paper
• The DST as a predictor of outcome in depression: a meta-analysis.

  1993cited by this paper
• Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.

  1993cited by this paper
• Reliability and validity of the symptoms of major depressive illness.

  1986cited by this paper

• Relationships between serotonin availability and frontolimbic response to fearful and threatening faces

  2023cites this paper
• The Emerging Role of SPECT Functional Neuroimaging in Schizophrenia and Depression

  2021cites this paper
• Early post‐treatment blood oxygenation level‐dependent responses to emotion processing associated with clinical response to pharmacological treatment in major depressive disorder

  2021cites this paper
• Spontaneous thought-related network connectivity predicts sertraline effect on major depressive disorder

  2020cites this paper
• Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder

  2020cites this paper
• Molecular Imaging of Depressive Disorders

  2020cites this paper
• Psychoradiological Biomarkers for Psychopharmaceutical Effects.

  2020cites this paper
• Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study

  2017cites this paper
• Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response

  2017cites this paper
• Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder.

  2017cites this paper
• Amygdala responses to quetiapine XR and citalopram treatment in major depression: the role of 5‐HTTLPR‐S/Lg polymorphisms

  2016influential citation
• Biological predictors of pharmacological therapy in anxiety disorders

  2015cites this paper
• Quantifying Midbrain Serotonin Transporter in Depression: A Preliminary Study of Diagnosis and Naturalistic Treatment Outcome

  2015cites this paper
• Imaging predictors of remission to anti-depressant medications in major depressive disorder.

  2015cites this paper
• Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM

  2015influential citation
• Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor.

  2015cites this paper
• The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression.

  2015cites this paper
• Associations of low testosterone levels with stress vulnerability and antidepressant response in aging males

  2015cites this paper
• Extrastriatal binding of [123I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls

  2014cites this paper
• Imaging of the Antidepressant Drug Response Using SPECT and PET

  2014cites this paper
• Positron Emission Tomography Molecular Imaging in Late-Life Depression

  2014cites this paper
• (11) C and (18) F PET radioligands for the serotonin transporter (SERT).

  2013cites this paper
• Brain SERT Expression of Male Rats Is Reduced by Aging and Increased by Testosterone Restitution

  2013influential citation
• Brain Imaging and the Prediction of Treatment Outcomes in Mood and Anxiety Disorders

  2013cites this paper
• Fluorinated tropanes.

  2013cites this paper
• Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas

  2012cites this paper
• Availability of brain serotonin transporters (5-HTT) is associated with low positive mood in healthy elderly subjects.

  2012cites this paper
• Association between somatization subscale score and serotonin transporter availability in healthy volunteers—a single photon emission computed tomography study with [123I] ADAM

  2012cites this paper
• Serotonin transporter genotype and function in relation to antidepressant response in Koreans

  2012cites this paper
• Imaging treatment effects in depression

  2012cites this paper
• The implication of functional connectivity strength in predicting treatment response of major depressive disorder: a resting EEG study.

  2011cites this paper
• Predictors of fluoxetine remission for hospitalized patients with major depressive disorder

  2011cites this paper
• Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.

  2011cites this paper
• Functional neuroimaging in geriatric depression.

  2011cites this paper
• In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease.

  2010cites this paper
• SPECT imaging with the serotonin transporter radiotracer [123I]p ZIENT in nonhuman primate brain.

  2010cites this paper
• Midbrain SERT in degenerative parkinsonisms: A 123I‐FP‐CIT SPECT study

  2010cites this paper
• Accelerating response to antidepressant treatment in depression: a review and clinical suggestions.

  2010cites this paper
• Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

  2009cites this paper
• Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram

  2009influential citation
• Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder

  2009cites this paper
• Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

  2009cites this paper
• Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy

  2009cites this paper
• Nuklearmedizinische Bildgebung bei depressiven Störungen und antidepressiver Therapie

  2009cites this paper
• Diencephalic serotonin transporter availability predicts both transporter occupancy and treatment response to sertraline in obsessive-compulsive checkers.

  2009cites this paper
• SEROTONIN TRANSPORTER GENE PROMOTER POLYMORPHISMS MODIFY THE ASSOCIATION BETWEEN PAROXETINE SEROTONIN TRANSPORTER OCCUPANCY AND CLINICAL RESPONSE IN MAJOR DEPRESSIVE DISORDER

  2009cites this paper
• Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.

  2008cites this paper
• The Scientific Building Blocks of PeaceBuilders Nine Key Principles of the Science of PeaceBuilding

  2008cites this paper
• Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.

  2008cites this paper
• Lithium overcomes the influence of 5-HTTLPR gene polymorphism on antidepressant response to sleep deprivation.

  2008cites this paper
• Predicting Positive and Negative Treatment Responses to Stimulants with Brain SPECT Imaging

  2008cites this paper
• High-Dose Ziprasidone Monotherapy in Bipolar I Disorder Patients With Depressed or Mixed Episodes

  2008cites this paper
• Dose-escalation in the picture : pharmacological and imaging studies in depression

  2008cites this paper
• Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain.

  2007cites this paper
• Association between serotonin transporter availability and hostility scores in healthy volunteers - a single photon emission computed tomography study with [(123)I] ADAM.

  2007cites this paper
• [123I] ADAM brainstem binding correlates with the loudness dependence of auditory evoked potentials

  2007cites this paper
• Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment.

  2007cites this paper
• Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER.

  2007cites this paper
• A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain

  2007cites this paper
• Pharmacotherapy of personality disorders

  2007cites this paper
• The Effect of Duloxetine on Primary Pain Symptoms in Parkinson Disease

  2007cites this paper
• The Interface of Oxytocin-Labeled Cells and Serotonin Transporter-Containing Fibers in the Primate Hypothalamus: A Substrate for SSRIs Therapeutic Effects?

  2007cites this paper
• Nuclear medicine in psychiatry.

  2007cites this paper
• für die Darstellung eines innovativen Radioliganden zur Untersuchung des serotonergen Systems sowie dessen erste präklinische Evaluierung am Menschen

  2007cites this paper
• From the Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  2007cites this paper
• Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging.

  2007cites this paper
• Relationship of brainstem raphe echogenicity and clinical findings in depressive states.

  2007cites this paper
• Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.

  2006cites this paper
• Brain kinetics of the new selective serotonin transporter tracer [(123)I]ADAM in healthy young adults.

  2006cites this paper
• Monoaminerge Funktion bei depressiven Patienten

  2006cites this paper
• Sex differences in diencephalon serotonin transporter availability in major depression.

  2006cites this paper
• Regression with Signals and Images as Predictors

  2006cites this paper
• Serotonin Transporter Imaging with [123I]β-CIT SPECT before and after One Year of Citalopram Treatment of Obsessive-Compulsive Disorder

  2006cites this paper
• Serotonin transporter residual availability during long-term antidepressant therapy does not differentiate responder and nonresponder unipolar patients.

  2006cites this paper
• Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM

  2006influential citation
• From THE DEPARTMENT OF CLINICAL NEUROSCIENCE Karolinska Institutet, Stockholm, Sweden PET STUDIES OF THE SEROTONIN TRANSPORTER IN THE HUMAN BRAIN

  2006cites this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper
• Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study

  2006influential citation
• [Monoaminergic function in major depression. A possibly helpful tool for choosing treatment strategy].

  2006cites this paper
• ASSOCIATION OF THE 5-HTTLPR WITH PROLACTIN RESPONSE TO CITALOPRAM IN A COMMUNITY POPULATION

  2005cites this paper
• Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression‐like behaviour: effects of chronic paroxetine treatment

  2005cites this paper
• Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.

  2005cites this paper